NASDAQ:SLS

SELLAS Life Sciences Group Stock Forecast, Price & News

$8.58
-0.11 (-1.27 %)
(As of 07/30/2021 12:11 PM ET)
Add
Compare
Today's Range
$8.55
$8.72
50-Day Range
$8.29
$13.71
52-Week Range
$1.76
$19.38
Volume3,366 shs
Average Volume1.12 million shs
Market Capitalization$129.43 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58
30 days | 90 days | 365 days | Advanced Chart
Receive SLS News and Ratings via Email

Sign-up to receive the latest news and ratings for SELLAS Life Sciences Group and its competitors with MarketBeat's FREE daily newsletter.


SELLAS Life Sciences Group logo

About SELLAS Life Sciences Group

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of immunotherapeutic for cancer indications. The firm's product pipeline includes galinpepimut-S and nelipepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.70 out of 5 stars

Medical Sector

685th out of 2,171 stocks

Pharmaceutical Preparations Industry

349th out of 858 stocks

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











SELLAS Life Sciences Group (NASDAQ:SLS) Frequently Asked Questions

Is SELLAS Life Sciences Group a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SELLAS Life Sciences Group in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SELLAS Life Sciences Group stock.
View analyst ratings for SELLAS Life Sciences Group
or view top-rated stocks.

What stocks does MarketBeat like better than SELLAS Life Sciences Group?

Wall Street analysts have given SELLAS Life Sciences Group a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SELLAS Life Sciences Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting SELLAS Life Sciences Group?

SELLAS Life Sciences Group saw a increase in short interest during the month of July. As of July 15th, there was short interest totaling 1,130,000 shares, an increase of 28.9% from the June 30th total of 876,900 shares. Based on an average trading volume of 583,000 shares, the days-to-cover ratio is presently 1.9 days.
View SELLAS Life Sciences Group's Short Interest
.

When is SELLAS Life Sciences Group's next earnings date?

SELLAS Life Sciences Group is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for SELLAS Life Sciences Group
.

How were SELLAS Life Sciences Group's earnings last quarter?

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) posted its quarterly earnings data on Thursday, May, 13th. The company reported ($0.16) earnings per share for the quarter. The firm had revenue of $5.70 million for the quarter.
View SELLAS Life Sciences Group's earnings history
.

How has SELLAS Life Sciences Group's stock been impacted by COVID-19?

SELLAS Life Sciences Group's stock was trading at $2.14 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SLS stock has increased by 303.7% and is now trading at $8.64.
View which stocks have been most impacted by COVID-19
.

When did SELLAS Life Sciences Group's stock split? How did SELLAS Life Sciences Group's stock split work?

Shares of SELLAS Life Sciences Group reverse split before market open on Friday, November 8th 2019. The 1-50 reverse split was announced on Wednesday, November 6th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 7th 2019. An investor that had 100 shares of SELLAS Life Sciences Group stock prior to the reverse split would have 2 shares after the split.

What price target have analysts set for SLS?

4 analysts have issued 12-month price targets for SELLAS Life Sciences Group's shares. Their forecasts range from $16.50 to $21.00. On average, they anticipate SELLAS Life Sciences Group's stock price to reach $18.38 in the next twelve months. This suggests a possible upside of 112.7% from the stock's current price.
View analysts' price targets for SELLAS Life Sciences Group
or view top-rated stocks among Wall Street analysts.

Who are SELLAS Life Sciences Group's key executives?

SELLAS Life Sciences Group's management team includes the following people:
  • Angelos M. Stergiou, President, Chief Executive Officer & Director
  • John T. Burns, Chief Accounting Officer, VP-Finance & Controller
  • Dragan Cicic, Senior Vice President-Clinical Development
  • Barbara A. Wood, Secretary, Executive VP & General Counsel

Who are some of SELLAS Life Sciences Group's key competitors?

What is SELLAS Life Sciences Group's stock symbol?

SELLAS Life Sciences Group trades on the NASDAQ under the ticker symbol "SLS."

How do I buy shares of SELLAS Life Sciences Group?

Shares of SLS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SELLAS Life Sciences Group's stock price today?

One share of SLS stock can currently be purchased for approximately $8.64.

How much money does SELLAS Life Sciences Group make?

SELLAS Life Sciences Group has a market capitalization of $130.33 million and generates $1.90 million in revenue each year. The company earns $-16,760,000.00 in net income (profit) each year or ($2.11) on an earnings per share basis.

How many employees does SELLAS Life Sciences Group have?

SELLAS Life Sciences Group employs 60 workers across the globe.

What is SELLAS Life Sciences Group's official website?

The official website for SELLAS Life Sciences Group is www.sellaslifesciences.com.

Where are SELLAS Life Sciences Group's headquarters?

SELLAS Life Sciences Group is headquartered at 15 WEST 38TH STREET 10TH FLOOR, NEW YORK NY, 10018.

How can I contact SELLAS Life Sciences Group?

SELLAS Life Sciences Group's mailing address is 15 WEST 38TH STREET 10TH FLOOR, NEW YORK NY, 10018. The company can be reached via phone at (646) 200-5278 or via email at [email protected]


This page was last updated on 7/30/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.